Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.

[1]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[2]  P. Grigsby,et al.  Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. , 2007, JAMA.

[3]  A. Gadducci,et al.  Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. , 2007, Gynecologic oncology.

[4]  P. Grigsby The role of FDG-PET/CT imaging after radiation therapy. , 2007, Gynecologic oncology.

[5]  A. Gadducci,et al.  Follow-up strategies in gynecological oncology: searching appropriateness , 2007, International Journal of Gynecologic Cancer.

[6]  H. Chung,et al.  Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. , 2006, Gynecologic oncology.

[7]  B. Cheson,et al.  Positron-emission tomography and assessment of cancer therapy. , 2006, The New England journal of medicine.

[8]  P. Grigsby,et al.  Preoperative lymph node staging of early‐stage cervical carcinoma by [18F]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography , 2005, Cancer.

[9]  J. Unger,et al.  Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. , 2004, Gynecologic oncology.

[10]  Imran Zoberi,et al.  Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  C. Haie-meder,et al.  Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  A. Berchuck,et al.  The role of PET scanning in the detection of recurrent cervical cancer. , 2003, Gynecologic oncology.

[13]  C. Choi,et al.  Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  P. Grigsby,et al.  FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[15]  M. Plummer,et al.  Strategies for HPV prevention. , 2002, Virus research.

[16]  F Dehdashti,et al.  Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Wharton,et al.  Posttherapy surveillance of women with cervical cancer: an outcomes analysis. , 2000, Gynecologic oncology.

[18]  R L Wahl,et al.  Evaluation of FDG PET in patients with cervical cancer. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[20]  N. Breslow A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship , 1970 .